Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
about
How does the efficacy and safety of Oralair(®) compare to other products on the market?Sublingual immunotherapy: World Allergy Organization position paper 2013 update."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined scoreGuideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical AssoDistinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapyA comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis.Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience.Selection of patients for sublingual versus subcutaneous immunotherapy.Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.Sublingual allergen immunotherapy for respiratory allergies: what is new?Updating the role played by immunotherapy for allergic rhinitis: meta-analysis.Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany.Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.Is clinical tolerance possible after allergen immunotherapy?Sublingual immunotherapy for allergic rhinitis: where are we now?Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.Similar biological activity in skin prick test for Oralair(®) (8200 BAU) and Grazax(®) (6200 BAU) reinforces effective SLIT dosing level.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens.Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain.Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trials.Allergen-specific immunotherapySublingual allergen immunotherapy for respiratory allergy: a systematic reviewDuration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis
P2860
Q26745596-8DCFEA4A-37BD-4337-96A0-E41350C71513Q30440195-F4E5C895-3875-46D6-9098-5DDD6DCB20FDQ35564301-2D1A456E-E5E6-42DE-AC59-3FCAF33A30C8Q35761230-B8E0089C-FEA5-496E-8C39-A93F6C12CB3CQ35777126-59BE3CC6-2DEB-4AD2-B215-765BD320BA20Q36619339-243A783E-7FBF-4262-90ED-21EE0B1D2557Q38207691-59BCC56F-DC09-41E0-A798-05D9B1BA7316Q38247821-9BD3CE4D-5282-4ED4-9EFA-647AEA913D28Q38257644-3DA1980D-6F27-45FD-92FB-25267F9C84E1Q38262168-3F5952EA-3B87-4729-88BA-B18758CF20BDQ38269285-9455D7EB-2B29-4123-93AA-8BAC70B6DDD3Q38271427-2BE5BF56-6378-42C8-BE26-4F79C65D9015Q38359800-A9E9BDFB-39B6-437E-9812-D9BC6D53ADDFQ38366788-3109095C-0F38-4423-A614-067F5059B31AQ38542313-EA0F2F06-4E6C-44BB-A00E-94BCD15F2567Q38617692-29A1C9C5-02EA-4A49-AE49-3CC9EFFDD4B0Q38792200-D14037E6-3649-4A1B-ADE7-0D00F69925FDQ40639452-783D78E9-2539-412B-950C-19F7800C615FQ47764778-F9A5D67C-387D-46F9-B762-6C50F2CE489AQ49163817-9DCEFDB6-FC55-497B-94E8-1F246D378332Q49375434-CA317C1E-8A60-4D38-A46A-DA6EEBCDF721Q53714415-56CEB8AB-8EB3-475A-85F0-44A009D1DC9DQ57111909-6294C2F4-85A8-4226-AF04-971344F0A3C9Q58700135-71ABB3ED-6F07-4F1B-9ACE-1953C5E8A1CEQ58780229-56C41806-C4CA-4AF1-98AB-A2CE1739B2DD
P2860
Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@en
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@nl
type
label
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@en
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@nl
prefLabel
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@en
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@nl
P2093
P2860
P356
P1476
Post-treatment efficacy of dis ...... allergic rhinoconjunctivitis.
@en
P2093
H-J Malling
R K Zeldin
P2860
P304
P356
10.1111/CEA.12100
P577
2013-05-01T00:00:00Z